ClinicalTrials.govpublic full text
A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients
p1b: advanced solid tumors, p2: biliary tract cancer, vegf, dll4, solid tumors, bispecific antibody, anti-angiogenic, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 885435
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.